WG G: Regulations & Risk Governance

WG G: Regulations & Risk Governance

Chair: Tom van Teunenbroek (NL); Co-chair: Thomas Kuhlbush (D) and Steffi Friedrichs (B)

Projects contributing: GOV4NANO, RISKGONE, CALIBRATE, NANORIGO

Scope:

Unlike other working groups within the NSC, this WG will serve as interface between science and regulations. As such, the activities are not centered on scientific research questions and opportunities but rather use scientific findings in different settings such as setting standards and developing internationally harmonized/accepted guidelines. Moreover regulatory (information) needs will be transferred back to the scientific community in order to develop a targeted research roadmap. This group is also established to coordinate and to ensure relevance of research priorities.

Participants/membership:

Representatives from governmental knowledge and research institutes and agencies involved in regulatory science and risk analysis (chemical) regulations such as JRC, (EC), BauA (D), BfR (D), PHE (UK), ANSES (F), INERIS (F), ISS (I), EMPA (CH), FPOH (CH), JRC, ECHA and EFSA.

Cooperation:

  • International: This WG will also interact with similar bodies outside the EU, such as China, Canada, ‘Asia NSF’, Korea, South Africa, Mexico, USA (GRSR (Anil Pati))
  • A link with pharma should be made (CBG (NL), EMA)
  • Link with metrology institutes

 

Proposed actions:

  • Translate regulatory questions into research/scientific questions  
  • Monitor for state of the art knowledge and interpret it for regulatory impact
  • Translate research/scientific findings toward regulators and policymakers
  • Facilitate transdisciplinary/transregulatory alignment of scientific issues
  • Monitor status of knowledge ready for implementation in guidance and guidelines
  • Explore/identify alternative approaches and their value or hurdles for acceptance by regulatory risk assessors/standardization bodies
  • Assure a common language between science and regulators/policymakers
  • Promote adoption of safe(r) by design approached in regulations and risk assessment
  • Initiate international arrangements of joined funding (public-public as well as public-private) for scientific questions to address regulatory needs
  • Lobby for funding including FP9 aiming for global cooperation
  • Develop a COST-action
  • Provide guidance to the EU High Level group on research priority.